Robert Rooks is listed as a director on 1 SEC Form D filing by 1 issuer in Dec 2011: RADIENT PHARMACEUTICALS Corp (Tustin, CA — pharmaceuticals — 2011; $11M reported sold to 37 investors).
What this means One deal on file with the SEC, filed Dec 2011. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Akio Ariura (1 shared filing), Douglas MacLellan (1 shared filing), Leonard Reyno (1 shared filing), Michael Boswell (1 shared filing) and Robert Beart (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Robert. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 4 court cases matching the name, 3 SEC releases, 8 bankruptcy cases matching the name listed in Key records below.
What this means 15 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Robert Rooks and found 1 difference: No amendment in the last 12 months on an offering that may still be open.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.